{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T08:01:04Z","timestamp":1772697664731,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2015.11.021","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T00:42:57Z","timestamp":1447893777000},"page":"846-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003\u20132011"],"prefix":"10.1016","volume":"34","author":[{"given":"Altynay","family":"Shigayeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wallis","family":"Rudnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter H.B.","family":"Demczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne L.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Gubbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agron","family":"Plevneshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Pong-Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"McGeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2015.11.021_bib0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1469-0691.2012.03937.x","article-title":"Understanding the burden of pneumococcal disease in adults","volume":"18","author":"Blasi","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0265","doi-asserted-by":"crossref","first-page":"e60273","DOI":"10.1371\/journal.pone.0060273","article-title":"Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques","volume":"8","author":"Said","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0270","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10096-012-1778-4","article-title":"The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis","volume":"32","author":"Rozenbaum","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0275","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3810\/pgm.2010.03.2130","article-title":"Burden of community-acquired pneumonia in North American adults","volume":"122","author":"File","year":"2010","journal-title":"Postgrad Med"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0280","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/thoraxjnl-2011-201092","article-title":"Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia","volume":"67","author":"Bewick","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0285","doi-asserted-by":"crossref","first-page":"e72743","DOI":"10.1371\/journal.pone.0072743","article-title":"Serotype distribution in non-bacteremic pneumococcal pneumonia: association with disease severity and implications for pneumococcal conjugate vaccines","volume":"8","author":"Benfield","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0290","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/infdis\/jit506","article-title":"Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged >\/=50 years with community-acquired pneumonia","volume":"208","author":"Sherwin","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0295","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/jac\/dkq480","article-title":"Serotypes and genotypes of Streptococcus pneumoniae causing pneumonia and acute exacerbations in patients with chronic obstructive pulmonary disease","volume":"66","author":"Domenech","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0300","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0305","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1016\/j.vaccine.2013.09.049","article-title":"Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995\u20132011","volume":"31","author":"Rudnick","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0310","series-title":"Immunization Coverage Report for School Pupils: 2012\u201313 School Year","author":"Ontario Agency for Health Protection and Promotion (Public Health Ontario).","year":"2014"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0315","series-title":"Estimates of population by census division, sex and age group based on the Standard Geographical Classification (SGC), annual (persons). Statistics Canada.","author":"Statistics Canada","year":"2006"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0320","series-title":"Manual of Clinical Microbiology","first-page":"405","article-title":"Streptococcus","author":"Spellerberg","year":"2011"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0325","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/JCM.42.6.2518-2522.2004","article-title":"Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-Latex)","volume":"42","author":"Slotved","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0330","first-page":"699","article-title":"The Quellung reaction, a neglected microbiologic technique","volume":"43","author":"Austrian","year":"1976","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0335","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00005792-200007000-00002","article-title":"Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study","volume":"79","author":"Musher","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0340","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/423820","article-title":"Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children","volume":"190","author":"Brueggemann","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0345","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0350","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.vaccine.2014.02.096","article-title":"Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults","volume":"32","author":"Grabenstein","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0355","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/655828","article-title":"Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis","volume":"51","author":"Weinberger","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2015.11.021_bib0360","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1099\/jmm.0.028803-0","article-title":"Death or survival from invasive pneumococcal disease in Scotland: associations with serogroups and multilocus sequence types","volume":"60","author":"Inverarity","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0365","doi-asserted-by":"crossref","first-page":"e1000081","DOI":"10.1371\/journal.pmed.1000081","article-title":"Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study","volume":"6","author":"Harboe","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0370","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/499242","article-title":"Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen","volume":"42","author":"Sjostrom","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0375","doi-asserted-by":"crossref","first-page":"e39150","DOI":"10.1371\/journal.pone.0039150","article-title":"Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes","volume":"7","author":"van Hoek","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0380","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3201\/eid2103.140634","article-title":"Risk factors for death from invasive pneumococcal disease, Europe, 2010","volume":"21","author":"Navarro-Torn\u00e9","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0385","unstructured":"NACI (The National Advisory Committee on Immunization). The Canadian Immunization Guide, Part 4, Active Vaccines, Pneumococcal Vaccine. The Public Health Agency of Canada. Available at: http:\/\/www.phac-aspc.gc.ca\/publicat\/cig-gci\/p04-pneu-eng.php (accessed 26.07.15)."},{"key":"10.1016\/j.vaccine.2015.11.021_bib0390","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10096-014-2062-6","article-title":"Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology","volume":"33","author":"Fletcher","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0395","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/CVI.00765-12","article-title":"Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey","volume":"20","author":"Ceyhan","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0400","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/586747","article-title":"Pneumococcal necrotizing pneumonia in Utah: does serotype matter?","volume":"46","author":"Bender","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0405","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/INF.0b013e3181db03a7","article-title":"Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children","volume":"29","author":"Bender","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0410","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1183\/09031936.00050413","article-title":"Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes","volume":"43","author":"Burgos","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0415","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/cid\/civ287","article-title":"Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged \u22652 years: an open-label study","volume":"61","author":"Cordonnier","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0420","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/CVI.00711-14","article-title":"Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults \u2265 50 years of age in Mexico","volume":"22","author":"Tinoco","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0425","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/cid\/cit428","article-title":"Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial","volume":"57","author":"Dagan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0430","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0435","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0440","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0445","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.vaccine.2010.10.032","article-title":"Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease","volume":"29","author":"Yildirim","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0450","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1128\/JCM.01524-08","article-title":"Occurrence, distribution, and origins of Streptococcus pneumoniae Serotype 6C, a recently recognized serotype","volume":"47","author":"Jacobs","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0455","doi-asserted-by":"crossref","first-page":"e60848","DOI":"10.1371\/journal.pone.0060848","article-title":"Epidemiology of Streptococcus pneumoniae serogroup 6 isolates from IPD in children and adults in Germany","volume":"8","author":"van der Linden","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0460","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.diagmicrobio.2013.11.017","article-title":"Prevalence and molecular characterisation of Streptococcus pneumoniae serotype 6C in Queensland, Australia","volume":"78","author":"Staples","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0465","doi-asserted-by":"crossref","first-page":"e0131494","DOI":"10.1371\/journal.pone.0131494","article-title":"Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0470","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1016\/j.vaccine.2014.04.066","article-title":"European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era","volume":"32","author":"Navarro Torn\u00e9","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0475","doi-asserted-by":"crossref","first-page":"e112337","DOI":"10.1371\/journal.pone.0112337","article-title":"Effect of pneumococcal conjugate vaccination in Uruguay, a middle-income country","volume":"9","author":"Garc\u00eda Gabarrot","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0480","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/cid\/ciu366","article-title":"Outbreak of invasive Streptococcus pneumoniae serotype 12F among a marginalized inner-city population in Winnipeg, Canada, 2009\u20132011","volume":"59","author":"Schillberg","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0485","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/clinids\/22.6.973","article-title":"Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease","volume":"22","author":"Scott","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0490","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1128\/JCM.01937-09","article-title":"Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease","volume":"48","author":"Imohl","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0495","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0500","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/CDLI.5.2.176-180.1998","article-title":"Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in two Chilean cities","volume":"5","author":"Inostroza","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2015.11.021_bib0505","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/00333549111260S313","article-title":"Changing disparities in invasive pneumococcal disease by socioeconomic status and race\/ethnicity in Connecticut, 1998\u20132008","volume":"126","author":"Soto","year":"2011","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2015.11.021_bib0510","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/INF.0b013e3181bdbed5","article-title":"Invasive pneumococcal disease in Alaskan children: impact of the seven-valent pneumococcal conjugate vaccine and the role of water supply","volume":"29","author":"Wenger","year":"2010","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15016412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15016412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T15:11:40Z","timestamp":1599837100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15016412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X15016412"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003\u20132011","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}